Clinical Trial Update: Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II study evaluating a combination of thalidomide, clarithromycin, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Thalidomide (thalidomide)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-23